Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles

About 5% of Triple negative breast cancer patients (TNBCs) who receive neoadjuvant chemotherapy (NAC) experience progressive disease (PD). Few reports are published on TNBCs with PD during NAC, whereas TNBCs that respond to NAC have been well-studied. We investigated kinase activity profiles of TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Takeshi, Hilhorst, Riet, Rangarajan, Savithri, Yoshida, Masayuki, Tanabe, Yuko, Tamura, Kenji, Kinoshita, Takayuki, Shimoyama, Tatsu, van Beuningen, Rinie, Ruijtenbeek, Rob, Tsuda, Hitoshi, Koizumi, Fumiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188135/
https://www.ncbi.nlm.nih.gov/pubmed/30344939
http://dx.doi.org/10.18632/oncotarget.26026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188135/
https://www.ncbi.nlm.nih.gov/pubmed/30344939
http://dx.doi.org/10.18632/oncotarget.26026

Ejemplares similares